2020
DOI: 10.21203/rs.2.23306/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations and outcome in Stage I-II colonic carcinoma.

Abstract: Background: The purpose of this paper is to investigate the immune function of the tumor microenvironment and its clinical correlation with colonic carcinoma. Methods : Immune genes were downloaded from the The Cancer Genome Atlas (TCGA)database. Five subtypes are obtained by cluster screening based on immune gene expression data. Results: The C3 and C4 subtypes show stronger immune activity. In addition, the C4 subtype has the largest number of gene mutations and the worst prognosis. Most of the immune signat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 23 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?